StonvexLoading…
StonvexStonvexStonvexCore line items from WS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-05-31 | Annual 2024 2024-05-31 | Annual 2023 2023-05-31 | Annual 2022 2022-05-31 |
|---|---|---|---|---|
Revenue | $3.09B | $3.43B | $3.61B | $4.07B |
Operating Income | $147.00M | $194.50M | $120.30M | $226.60M |
Net Income | $110.70M | $154.70M | $87.10M | $180.40M |
EPS (Diluted) | $2.19 | $3.11 | $1.77 | $3.66 |
Total Assets | $1.96B | $1.87B | $1.76B | Not available |
Total Liabilities | $763.90M | $748.90M | $609.80M | Not available |
Cash & Equivalents | $38.00M | $40.20M | $32.70M | $20.10M |
Free Cash Flow OCF − CapEx | $99.90M | $96.10M | $269.50M | $3.10M |
Shares Outstanding | 49.55M | 49.33M | 100 | 49.30M |